Zhiqiang Li1,2,3,4, Hong-Lei Liu5, Jianhua Chen2,3,6, Ting Zeng7, Lin He2,4, Meihang Li8, Cainan Luo9, Shuang Liu10, Ting-Ting Ding11, Kuerbanjiang Yimaiti9, Jialin Teng5, Xingwang Li2, Yonghe Ding8, Xiaobing Cheng5, Juan Zhou2, Junna Ye5, Jue Ji2, Yu-Tong Su5, Hui Shi5, Yue Sun5, Chengwen Gao8, Qiongyi Hu5, Huihui Chi5, Xuan Yuan12, Zhuochao Zhou5, Dong Wang2, Ke Wang2, Chang-Gui Li12, Yuanchao Sun8, Yujuan Niu8, Lin-Jie Chen11, Jian Xu10, Lijun Wu9, Zhaowei Zhou2, Dun Pan2, Haitao Niu1,13,14, Yongyong Shi1,2,3,4,6,15,16, Chengde Yang17. 1. The Affiliated Hospital of Qingdao University & The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China yangchengde@sina.com shiyongyong@gmail.com lizqsjtu@163.com niuht0532@126.com. 2. Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), The Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China. 3. Shanghai Key Laboratory of Sleep Disordered Breathing, Shanghai, China. 4. Institute of Neuropsychiatric Science and Systems Biological Medicine, Shanghai Jiao Tong University, Shanghai, China. 5. Department of Rheumatology and Immunology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China. 6. Shanghai Key Laboratory of Psychotic Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. 7. Xinhua Hospital Chongming Branch Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. 8. The Affiliated Hospital of Qingdao University & The Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China. 9. Department of Rheumatology and Immunology, The People's Hospital of Xinjiang Ugyur Autonomous Region, Urumqi, China. 10. Department of Rheumatology and Immunology, First Affiliated Hospital of Kunming Medical University, Kunming, China. 11. Department of Rheumatology and Immunology, First Affiliated Hospital of Bengbu Medical College, Bengbu, China. 12. Shandong Provincial Key Laboratory of Metabolic Disease, The Affiliated Hospital of Qingdao University, Qingdao, China. 13. Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, China. 14. Key Laboratory, Department of Urology and Andrology, The Affiliated Hospital of Qingdao University, Qingdao, China. 15. Department of Psychiatry, The First Teaching Hospital of Xinjiang Medical University, Urumqi, China. 16. Changning Mental Health Center, Shanghai, China. 17. Department of Rheumatology and Immunology, Shanghai Jiao Tong University Medical School Affiliated Ruijin Hospital, Shanghai, China yangchengde@sina.com shiyongyong@gmail.com lizqsjtu@163.com niuht0532@126.com.
Adult-onset Still's disease (AOSD) is a rare autoinflammatory condition with unclear aetiology and highly heterogeneous manifestations, such as spiking fever, skin rash and arthralgia (or arthritis).1 2 AOSD is usually the result of both genetic and environmental factors. However, only a few genetic loci have been associated with AOSD, and none of them have reached the threshold for genome-wide significance (GWS) of p<5×10−
8.[2 3] For example, HLA-DRB1 was strongly associated with AOSD in previous studies (the p value for the most significant association was 8.60×10−
6).3
HLA-DRB1 also influences the risk of systemic juvenile idiopathic arthritis (JIA),4 which presents similarly to AOSD but differs in age of onset. In addition, functional variations in periodic fever syndrome genes have been identified in some AOSD patients (Bonferroni corrected p values ranged from 2.34×10−
3 to 2.40×10−
4).5In this study, for the first time, we conducted a genome-wide association study (GWAS) to systematically screen genetic factors influencing susceptibility to AOSD (online supplementary text). Principal component analysis was adopted to evaluate population stratification between cases and controls and to detect outliers for removal (online supplementary figure S1). After quality control and imputation, a total of 3 547 931 variants in 264 AOSD cases and 2420 controls (discovery: 247 cases vs 2163 controls; replication: 17 cases vs 257 controls; online supplementary text and table S1) from China were analysed. The genomic inflation, λGC, was 1.018, indicating the presence of population stratification to a minimal degree (online supplementary figure S2). A total of 1281 variants, from the HLA class I and II regions, exceeded GWS in this analysis (online supplementary figure S3).The most significant association was with rs9268791 (OR=2.363, p=4.10×10−19; table 1 and figure 1A), located in the intergenic region between HLA-DRA and HLA-DRB5 (the HLA class II region). For the HLA class I region, the top GWS signal was observed for rs3094178 (OR=2.139, p=1.97×10−8; table 1 and figure 1B), which is located 19 kb downstream of HLA-G. Outside the HLA region, a suggestive association (p<10−5) was observed at VEGFC (rs514410, OR=2.211, p=1.81×10−6; online supplementary table S2, figure S4 and text).
Table 1
Summary statistics for the genome-wide significant association of single nucleotide polymorphisms with adult-onset Still's disease
SNP
Nearby gene(s)
Chr
Position (hg19)
Risk/non-risk allele
Stage*
RAF in cases
RAF in controls
OR
SE
P values
P_het
rs9268791
HLA-DRA|HLA-DRB5
6
32 421 073
T/C
Meta
–
–
2.363
0.096
4.10E−19
0.686
Discovery
0.468
0.273
2.389
0.100
2.85E−18
Replication
0.382
0.224
2.054
0.360
4.54E−02
rs3094178
HLA-G
6
29 818 000
C/G
Meta
–
–
2.139
0.135
1.97E−08
0.806
Discovery
0.875
0.769
2.116
0.143
1.48E−07
Replication
0.767
0.568
2.366
0.432
4.62E−02
*The discovery data set comprises 247 cases and 2163 controls from northern and central China. The replication data set comprises 17 cases and 257 controls from southern China.
Chr, chromosome;P_het, p value for heterogeneity test across different cohorts using Cochran's Q test; RAF, frequency of risk allele;SNP, single nucleotide polymorphism.
Figure 1
Regional association plots of the adult-onset Still's disease-associated HLA class I and II regions. (A) HLA class II region and (B) HLA class I region. Purple circles represent the most significantly associated single nucleotide polymorphisms (SNPs) (marker SNPs) in each region in the meta-analysis of discovery and replication. −log10p values (Y-axis) of the SNPs (within the regions spanning 500 kb on either side of the marker SNP) are presented according to the chromosomal positions of the SNPs (X-axis, hg19). SNPs are coloured according to their linkage disequilibrium (LD) with the marker SNP. The LD values were established based on the 1000 Genomes Asian (ASI) Data (March 2012). Estimated recombination rates with samples from the 1000 Genomes Project March 2012 release are shown as blue lines, and the genomic locations of genes within the regions of interest annotated from the University of California, Santa Cruz (UCSC) genome browser are shown as arrows.
Regional association plots of the adult-onset Still's disease-associated HLA class I and II regions. (A) HLA class II region and (B) HLA class I region. Purple circles represent the most significantly associated single nucleotide polymorphisms (SNPs) (marker SNPs) in each region in the meta-analysis of discovery and replication. −log10p values (Y-axis) of the SNPs (within the regions spanning 500 kb on either side of the marker SNP) are presented according to the chromosomal positions of the SNPs (X-axis, hg19). SNPs are coloured according to their linkage disequilibrium (LD) with the marker SNP. The LD values were established based on the 1000 Genomes Asian (ASI) Data (March 2012). Estimated recombination rates with samples from the 1000 Genomes Project March 2012 release are shown as blue lines, and the genomic locations of genes within the regions of interest annotated from the University of California, Santa Cruz (UCSC) genome browser are shown as arrows.Summary statistics for the genome-wide significant association of single nucleotide polymorphisms with adult-onset Still's disease*The discovery data set comprises 247 cases and 2163 controls from northern and central China. The replication data set comprises 17 cases and 257 controls from southern China.Chr, chromosome;P_het, p value for heterogeneity test across different cohorts using Cochran's Q test; RAF, frequency of risk allele;SNP, single nucleotide polymorphism.We explored regulatory annotations for the GWS SNPs and variants in strong linkage disequilibrium (LD) with them (r2>0.8) using HaploReg6 and RegulomeDB,7 and 94 SNPs had a RegulomeDB score from 1a–1f to 2a–2c, suggesting that they are located in regulatory regions with maximum evidence (online supplementary table S3). Of them, the top SNPs in each region were rs3115628 (p=2.92×10−8; HLA class I) and rs9268832 (p=3.41×10−18; HLA class II). In addition, the expression quantitative trait loci analyses suggested that rs9268832 was significantly associated with the expression of several genes (including HLA-DRB1, HLA-DRB6, HLA-DQA2 and HLA-DQB1; p<5×10−8) and that rs3115628 was significantly correlated with ZFP57 and four HLA pseudogenes (p<5×10−8) in different types of tissues (online supplementary table S4).8 Further studies are required to clarify the mechanisms underlying these associations.Previous GWAS of JIA on primarily European ancestry samples has also identified three GWS SNPs in the HLA region.9 10 However, none of them overlapped with the AOSD-associated markers identified in this study. Pair-wise LD analysis showed that these SNPs are in low LD (r2<0.1, online supplementary table S5). This finding suggests genetic heterogeneity in these diseases and across different populations.In summary, we identified the first GWS risk loci and indicated an important role for both HLA class I and II regions in the genetic architecture of AOSD using a genome-wide scan in a Chinese sample. Further replication studies of other populations are necessary to confirm our findings and to investigate the possible ancestral differences.
Authors: Alan P Boyle; Eurie L Hong; Manoj Hariharan; Yong Cheng; Marc A Schaub; Maya Kasowski; Konrad J Karczewski; Julie Park; Benjamin C Hitz; Shuai Weng; J Michael Cherry; Michael Snyder Journal: Genome Res Date: 2012-09 Impact factor: 9.043
Authors: Michael J Ombrello; Elaine F Remmers; Ioanna Tachmazidou; Alexei Grom; Dirk Foell; Johannes-Peter Haas; Alberto Martini; Marco Gattorno; Seza Özen; Sampath Prahalad; Andrew S Zeft; John F Bohnsack; Elizabeth D Mellins; Norman T Ilowite; Ricardo Russo; Claudio Len; Maria Odete E Hilario; Sheila Oliveira; Rae S M Yeung; Alan Rosenberg; Lucy R Wedderburn; Jordi Anton; Tobias Schwarz; Anne Hinks; Yelda Bilginer; Jane Park; Joanna Cobb; Colleen L Satorius; Buhm Han; Elizabeth Baskin; Sara Signa; Richard H Duerr; J P Achkar; M Ilyas Kamboh; Kenneth M Kaufman; Leah C Kottyan; Dalila Pinto; Stephen W Scherer; Marta E Alarcón-Riquelme; Elisa Docampo; Xavier Estivill; Ahmet Gül; Paul I W de Bakker; Soumya Raychaudhuri; Carl D Langefeld; Susan Thompson; Eleftheria Zeggini; Wendy Thomson; Daniel L Kastner; Patricia Woo Journal: Proc Natl Acad Sci U S A Date: 2015-11-23 Impact factor: 11.205
Authors: Anne Hinks; Joanna Cobb; Miranda C Marion; Sampath Prahalad; Marc Sudman; John Bowes; Paul Martin; Mary E Comeau; Satria Sajuthi; Robert Andrews; Milton Brown; Wei-Min Chen; Patrick Concannon; Panos Deloukas; Sarah Edkins; Stephen Eyre; Patrick M Gaffney; Stephen L Guthery; Joel M Guthridge; Sarah E Hunt; Judith A James; Mehdi Keddache; Kathy L Moser; Peter A Nigrovic; Suna Onengut-Gumuscu; Mitchell L Onslow; Carlos D Rosé; Stephen S Rich; Kathryn J A Steel; Edward K Wakeland; Carol A Wallace; Lucy R Wedderburn; Patricia Woo; John F Bohnsack; Johannes Peter Haas; David N Glass; Carl D Langefeld; Wendy Thomson; Susan D Thompson Journal: Nat Genet Date: 2013-04-21 Impact factor: 38.330
Authors: Michael J Ombrello; Victoria L Arthur; Elaine F Remmers; Anne Hinks; Ioanna Tachmazidou; Alexei A Grom; Dirk Foell; Alberto Martini; Marco Gattorno; Seza Özen; Sampath Prahalad; Andrew S Zeft; John F Bohnsack; Norman T Ilowite; Elizabeth D Mellins; Ricardo Russo; Claudio Len; Maria Odete E Hilario; Sheila Oliveira; Rae S M Yeung; Alan M Rosenberg; Lucy R Wedderburn; Jordi Anton; Johannes-Peter Haas; Angela Rosen-Wolff; Kirsten Minden; Klaus Tenbrock; Erkan Demirkaya; Joanna Cobb; Elizabeth Baskin; Sara Signa; Emily Shuldiner; Richard H Duerr; Jean-Paul Achkar; M Ilyas Kamboh; Kenneth M Kaufman; Leah C Kottyan; Dalila Pinto; Stephen W Scherer; Marta E Alarcón-Riquelme; Elisa Docampo; Xavier Estivill; Ahmet Gül; Carl D Langefeld; Susan Thompson; Eleftheria Zeggini; Daniel L Kastner; Patricia Woo; Wendy Thomson Journal: Ann Rheum Dis Date: 2016-12-07 Impact factor: 19.103